Combined effects of differentiation-apoptosis inducers on mice inoculated with human leukemia cells.
Combined effects of differentiation-apoptosis inducers on mice inoculated with human leukemia cells.
批准号:
06672239
负责人:
NAKAYA Kazuyasu
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have found that geranylgeraniol (GGO) is a potent inducer of apoptosis in various tumor cell lines including human myeloid leukemia, lymphoblastic, and adenocarcinoma. Upon treatment of HL-60 cells with 50 muM GGO, 85% of DNA was fragmented in 3 h. [^3H] GGO was taken up by HL-60 cells in 3 h and was incorporated into several proteins with molecular masses from 10.5 to 20.1 kDa, suggesting these proteins were geranylgeranylated. The expression of c-myc and bc1-2 decreased significantly within 3 h.To explore agents for differentiation-apoptosis therapy of leukemia, various combinations of differentiation-and apoptosis-inducers were examined for the strongest apoptosis-inducing activity for human HL-60 cells. The strongest apotosis-inducing acitvity on HL-60 cells were obtained by combining with retinoic acid, bufalin, and VP16. Administration of the combination of retinoic acid, bufalin, and VP16 to mice inoculated with HL-60 cells was makedly effective in prolongation of survival.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hidekazu OHIZUMI: "Geranylgeraniol is a potent inducer of apoptosis in tumor cells." J. Biochem.117. 11-13 (1995)
Hidekazu OHIZUMI:“香叶基香叶醇是肿瘤细胞凋亡的有效诱导剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Itaru SAKAI: "Novel role vitmin K2 : a potent inducer of differentiaionof various human myeloid leukemia cell lines" Biochem. Biophys. Res. Commun.205. 1305-1310 (1994)
Itaru SAKAI:“维生素 K2 的新作用:多种人类骨髓性白血病细胞系分化的有效诱导剂”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidekazu OHIZUMI: "Geranylgeraniol is a potent inducer of apoptosis in tumor cells." J.Biochem.117. 11-13 (1995)
Hidekazu OHIZUMI:“香叶基香叶醇是肿瘤细胞凋亡的有效诱导剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Itaru Sakai, Schiko Hashimoto, Madoka Yoda, Takayuki Hida, Shigemitsu Osawa, Shigeo Nakajo and kazuyasu Nakaya: "Role of vitamin K2 ; a potent inducer of differentiation of various human myeloid leukemia cell lines" Biochem.Biophys.Res.Commun.205. 1305-13
Itaru Sakai、Schiko Hashimoto、Madoka Yoda、Takayuki Hida、Shigemitsu Osawa、Shigeo Nakajo 和 kazuyasu Nakaya:“维生素 K2 的作用;各种人类骨髓性白血病细胞系分化的有效诱导剂”Biochem.Biophys.Res.Commun.205。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Itaru SAKAI: "Novel role of vitamin K2:a potent inducer of differentiaionof various human myeloid leukemia cell lines." Biochem.Biophys.Res.Commun.205. 1305-1310 (1994)
Itaru SAKAI:“维生素 K2 的新作用:多种人类骨髓性白血病细胞系分化的有效诱导剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
High resolution analysis of proteins associated with the induction of cell death and carcinogenesis of tumor cells development of chemopreventive agents
-
批准号:15590068
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:NAKAYA Kazuyasu
-
依托单位:
Development of a novel anti-cancer agent from a novel tyrosine kinase inhibitor
-
批准号:13672297
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:NAKAYA Kazuyasu
-
依托单位:
Studies on apoptosis-inducers targeted for the molecules associated with the induction of apoptosis in cancer cells
-
批准号:11672182
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:NAKAYA Kazuyasu
-
依托单位:
Effects of isoprenoid compounds on human solid cancer cells
-
批准号:09672251
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:NAKAYA Kazuyasu
-
依托单位:
MECHANISM OF INDUCTION OF DIFFRENTIATION INLEUKEMIA CELLS BY TOPOISOMERASE INHIBITORS
-
批准号:03671063
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:NAKAYA Kazuyasu
-
依托单位:
Research on a peptide differentiation factor for myeloid leukemia cells
-
批准号:60571058
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1985
-
负责人:NAKAYA Kazuyasu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
-
批准号:82370801
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李峰
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
TNFAIP8/Hippo/SIX1轴调控软骨干细胞分化能力在颞下颌骨关节炎中的机制研究
-
批准号:82370980
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:沈佩
-
依托单位:
细胞命运决定中不同蛋白水平OCT4A差异性调控CITED2转录的机制研究
-
批准号:32100597
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周艳文
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位: